Search Results 451-460 of 24075 for Crohns disease

  1. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    Long-lasting diarrhea and belly pain could be caused by inflammatory bowel disease, also called IBD. Learn about IBD causes, diagnosis and treatment.

  2. A Study to Evaluate the Effectiveness and Safety of Triple Combination Therapy in High Risk Crohn's Disease (CD) - Mayo Clinic

    A Study to Evaluate the Effectiveness and Safety of Triple Combination Therapy in High Risk Crohn's Disease (CD) · Overview · Participation eligibility.

  3. Stem Cell Fistula Plug in Perianal Crohn's Disease - Mayo Clinic

    ... Crohn's disease will be enrolled. Subjects will undergo standard adjuvant therapy including drainage of infection and placement of a draining seton with ...

  4. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy - Mayo Clinic

    To determine the efficacy and safety of multiple doses of ABT-494 in subjects with moderately to severely active Crohn's Disease with a history of inadequate ...

  5. Sharing Mayo Clinic: Lifting the weight of debilitating inflammatory bowel disease

    Ulcerative colitis and Crohn's disease are the two main types. Marissa began experiencing symptoms of inflammatory bowel disease when she was in her early 20s.

  6. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    Long-lasting diarrhea and belly pain could be caused by inflammatory bowel disease, also called IBD. Learn about IBD causes, diagnosis and treatment.

  7. Mayo Clinic Radio: IBD / food allergies / Convergence Science Program

    There are two common types: ulcerative colitis, which causes ulcers, or sores, in the lining of the large intestine and rectum, and Crohn's disease, which ...

  8. A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease - Mayo Clinic

    Clinical Trials · A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease · More about research at Mayo Clinic · Mayo Clinic Footer.

  9. A Study to Evaluate Safety and Effectiveness of SHP647 as Induction Therapy in Participants with Moderate-to- Severe Crohn's Disease - Mayo Clinic

    ... and endoscopic response in participants with moderate to severe Crohn's Disease. Participation eligibility. Participant eligibility includes age, gender ...

  10. Novel PRO Tool and Imaging Index Items Validation in Stricturing Crohn’s Disease - Mayo Clinic

    Novel PRO Tool and Imaging Index Items Validation in Stricturing Crohn's Disease · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...